Metabolic Imbalance Unlocks a New Pathway to Pancreatic Cancer Risk
A recent study published in Cell Death & Disease reveals a novel link between cellular metabolism and DNA repair that heightens susceptibility to pancreatic cancer. Researchers found that an imbalance in the ratio of α-ketoglutarate to succinate—key metabolites in the Krebs cycle—directly impairs the function of thymine DNA glycosylase (TDG), a critical enzyme in the base excision repair (BER) pathway. This metabolic dysregulation compromises the cell’s ability to fix DNA damage, leading to genomic instability and an increased likelihood of oncogenic transformation in pancreatic tissue. The findings highlight a previously underappreciated intersection of metabolic health, DNA integrity, and cancer etiology.
Study Significance: For nephrology professionals, this research underscores the systemic consequences of metabolic disturbances, which are central to conditions like diabetic nephropathy and chronic kidney disease (CKD). Understanding how metabolite ratios affect fundamental cellular processes like DNA repair could inform broader strategies for managing metabolic complications in renal patients and assessing their long-term cancer risk. It prompts a closer look at the extra-renal implications of metabolic control in CKD, potentially influencing monitoring protocols and integrative care approaches.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
